NEO

NeoGenomics, Inc.

14.93 USD
+0.13 (+0.88%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NeoGenomics, Inc. stock is up 8.42% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 11 May’s closed higher than April. In the last 4 Unusual Options Trades, there were 2 PUTs, 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Mar 16:45 17 May, 2024 12.50 PUT 966 460
19 Apr 19:49 17 May, 2024 12.50 PUT 1201 1231
29 Apr 17:02 16 Aug, 2024 10.00 CALL 50 289
17 May 19:17 16 Aug, 2024 20.00 CALL 786 740

About NeoGenomics, Inc.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.

  • BTIG
    Thu May 2, 13:42
    buy
    confirm
  • TD Cowen
    Wed May 1, 13:47
    buy
    confirm
  • Craig-Hallum
    Wed May 1, 13:19
    buy
    initial
  • Benchmark
    Wed May 1, 11:18
    buy
    confirm
  • Needham
    Tue Apr 30, 13:16
    buy
    confirm